Home > Insider Trading > Filing (0001140361-12-044061)

Filing Details

Accession Number:: 0001140361-12-044061
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-10-17 18:53:24
Reporting Period:: 2012-10-15

Filing Date:: 2012-10-17
Accepted Time:: 2012-10-17 18:53:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
3116	Akorn Inc	AKRX	Pharmaceutical Preparations (2834)	720717400

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1466630	A Timothy Dick	1925 West Field Court Suite 300 Lake Forest IL 60045	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-10-15	54,900	$1.00	87,721	No	4	M	Direct
Common Stock	Disposition	2012-10-15	54,900	$12.71	32,821	No	4	S	Direct
Common Stock	Acquisiton	2012-10-16	45,100	$1.00	77,921	No	4	M	Direct
Common Stock	Disposition	2012-10-16	45,100	$13.00	32,821	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2012-10-15	54,900	$0.00	54,900	$1.00
Common Stock	Stock Option (Right to Buy)	Disposition	2012-10-16	45,100	$0.00	45,100	$1.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
145,100		2014-06-12	No	4	M	Direct
100,000		2014-06-12	No	4	M	Direct

Footnotes

Reflects the weighted average sale prices of the shares sold. The shares were sold in multiple trades at prices ranging from $12.6730 to $13.0335 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
Includes additional purchases of Akorn Common Stock through Akorn's Employee Stock Purchase Plan of 7,352 shares on October 1, 2009, 7,389 shares on January 4, 2010 and 4,118 shares on January 18, 2012.
The options exercised are from a grant on June 12, 2009 of 350,000 options which are fully vested, with 116,666 shares having vested on June 12, 2010 and 116,667 shares having vested on each of June 12, 2011 and June 12, 2012. Of the 54,900 options exercised on October 15, 2012, 36,600 options became exercisable on June 12, 2010 and 18,300 options became exercisable on June 12, 2011. Of the 45,100 options exercised on October 16, 2012, 30,067 options became exercisable on June 12, 2010 and 15,033 options became exercisable on June 12, 2011.
This stock option exercise was made according to a duly filed 10b5-1 plan which allows for 200,000 total stock options from this option grant to be exercised over a six month period. All of these options have now traded and the plan is fully exercised. Derivative securities beneficially owned include previously reported Stock Option grants of 100,000 shares, 183,333 shares, 366,667 shares, and 125,000 shares granted on June 12, 2009, February 22, 2010, May 21, 2010, and April 29, 2011, respectively for a total of 775,000 stock options.
Reflects the weighted average sale prices of the shares sold. The shares were sold in multiple trades at prices ranging from $13.0000 to $13.0050 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.